Table 1 Previously reported antemortem diagnoses of PTTM
Year | Author | Primary site | Diagnostic method of PTTM | CT findings | PH | Treatment | Survival time |
|---|---|---|---|---|---|---|---|
2007 | Miyano et al. [5] | Stomach | VATS | Multiple tiny nodules | - | S-1 + dexamethasone + warfarin, aspirin | 9 months |
2008 | Noguchi et al. [12] | Stomach | TBLB | Tiny nodules | + | No treatment | 10 days |
2008 | Uruga et al. [8] | Lung | CT guided biopsy | Consolidation, ground glass attenuation | - | Carboplatin, paclitaxel | 7 months |
2011 | Ishiguro et al. [2] | Unknown | TBLB | Mild interlobular septal thickening, ground glass opacities | + | CHOP(cyclophosphamide, doxorubicin, vincristine, prednisolone) | 4 months |
2011 | Ueda et al. [7] | Esophagus | TBLB | Multiple bilateral diffuse interstitial infiltrative shadows | + | Fluorouracil, nedaplatin | 9 days |
2012 | Kayatani et al. [3] | Unknown | VATS | Centrilobular ultrafine granular shadows | - | S-1, cisplatin | 15 months |
2013 | Ogawa et al. [6] | Gastroduodenum | TBLB | A nodular shadow and septal thicken with a slight amount of pleural effusion | + | Bosentan, epoprostenol + imatinib + S-1, 5-fluorouracil | 9 months |
2013 | Kitamura et al. [4] | Breast | TBLB | Ground glass opacities around the bronchovascular bundles | - | Irinotecan + warfarin | 3 months |
2014 | Higo et al. [13] | Breast | Pulmonary wedge aspiration | Mosaic pattern | + | Bosentan, tadalafil + imatinib, bevacizumab + S-1 | 12 months |
2015 | Takahashi et al. (present case) | Breast | VATS | Peripheral consolidation in both lower lobes | - | Trastuzumab | 32 months |